tebipenem HBr — Regulatory decision
2H 2026
We are working alongside our partner, GSK, to enable them to submit the FDA filing this quarter and we anticipate regulatory decision in 2H 2026.Source filing
SPRO biotech catalysts & pipeline
SPERO THERAPEUTICS INC · Data as of 2026-09-08